Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
Abstract Pompe disease is a metabolic myopathy due to acid alpha‐glucosidase deficiency. In addition to glycogen storage, secondary dysregulation of cellular functions, such as autophagy and oxidative stress, contributes to the disease pathophysiology. We have tested whether oxidative stress impacts...
Enregistré dans:
Auteurs principaux: | Antonietta Tarallo, Carla Damiano, Sandra Strollo, Nadia Minopoli, Alessia Indrieri, Elena Polishchuk, Francesca Zappa, Edoardo Nusco, Simona Fecarotta, Caterina Porto, Marcella Coletta, Roberta Iacono, Marco Moracci, Roman Polishchuk, Diego Luis Medina, Paola Imbimbo, Daria Maria Monti, Maria Antonietta De Matteis, Giancarlo Parenti |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Wiley
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c9d76b1dfda5478da27f60239b67fa37 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
par: Alícia Dorneles Dornelles, et autres
Publié: (2021) -
Molecular study of Pompe disease in Egyptian infants
par: Mona Essawi, et autres
Publié: (2021) -
Importance of Timely Treatment Initiation in Infantile-Onset Pompe Disease, a Single-Centre Experience
par: Javier de las Heras, et autres
Publié: (2021) -
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report
par: Zhang B, et autres
Publié: (2016) -
AAV-mediated transcription factor EB (TFEB) gene delivery ameliorates muscle pathology and function in the murine model of Pompe Disease
par: Francesca Gatto, et autres
Publié: (2017)